CUSIP: 90269A302
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ETRACS MTH2XRE
-
Total 13F shares
-
395,694
-
Share change
-
+43,776
-
Total reported value
-
$7,381,000
-
Price per share
-
$18.65
-
Number of holders
-
14
-
Value change
-
+$815,722
-
Number of buys
-
6
-
Number of sells
-
2
Quarterly Holders Quick Answers
What is CUSIP 90269A302?
CUSIP 90269A302 identifies MORL - UBS AG LONDON BRH - ETRACS MTH2XRE in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of UBS AG LONDON BRH - ETRACS MTH2XRE (MORL) as of Q2 2017
As of 30 Jun 2017,
UBS AG LONDON BRH - ETRACS MTH2XRE (MORL) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
395,694 shares.
The largest 10 holders included
Creative Planning, Edge Advisors, LLC, Sigma Planning Corp, Kovack Advisors, Inc., CITADEL ADVISORS LLC, RAYMOND JAMES & ASSOCIATES, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, MORGAN STANLEY, IFP Advisors, Inc, and ROYAL BANK OF CANADA.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.